Dormont D

References (3)

Title : Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease - Cavedo_2017_Sci.Rep_7_11706
Author(s) : Cavedo E , Grothe MJ , Colliot O , Lista S , Chupin M , Dormont D , Houot M , Lehericy S , Teipel S , Dubois B , Hampel H
Ref : Sci Rep , 7 :11706 , 2017
Abstract :
PubMedSearch : Cavedo_2017_Sci.Rep_7_11706
PubMedID: 28916821

Title : Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer's disease - Teipel_2016_Neuropharmacol_108_128
Author(s) : Teipel SJ , Cavedo E , Grothe MJ , Lista S , Galluzzi S , Colliot O , Chupin M , Bakardjian H , Dormont D , Dubois B , Hampel H
Ref : Neuropharmacology , 108 :128 , 2016
Abstract :
PubMedSearch : Teipel_2016_Neuropharmacol_108_128
PubMedID: 26876309

Title : Monitoring of intracellular levels of 5'-monophosphate-AZT using an enzyme immunoassay - Goujon_1998_J.Immunol.Methods_218_19
Author(s) : Goujon L , Brossette T , Dereudre-Bosquet N , Creminon C , Clayette P , Dormont D , Mioskowski C , Lebeau L , Grassi J
Ref : Journal of Immunological Methods , 218 :19 , 1998
Abstract :
PubMedSearch : Goujon_1998_J.Immunol.Methods_218_19
PubMedID: 9819120